BTIG Research Forecasts Strong Price Appreciation for HealthEquity (NASDAQ:HQY) Stock

HealthEquity (NASDAQ:HQY) had its target price upped by research analysts at BTIG Research from $110.00 to $115.00 in a report released on Friday, MarketBeat reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price objective would suggest a potential upside of 21.51% from the stock’s previous close.

A number of other analysts also recently commented on the stock. Citizens Jmp boosted their price target on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Wall Street Zen lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, July 4th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Finally, Barrington Research restated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

HealthEquity Price Performance

NASDAQ HQY opened at $94.64 on Friday. The company has a 50-day moving average price of $90.21 and a two-hundred day moving average price of $84.94. HealthEquity has a 52 week low of $72.76 and a 52 week high of $105.96. The stock has a market cap of $7.91 billion, a price-to-earnings ratio of 35.45, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts forecast that HealthEquity will post 3.92 EPS for the current year.

Insider Activity

In other HealthEquity news, EVP Michael Henry Fiore sold 2,354 shares of the company’s stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president directly owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. This represents a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president owned 91,141 shares in the company, valued at $8,202,690. This represents a 7.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 over the last three months. Insiders own 1.60% of the company’s stock.

Institutional Trading of HealthEquity

Several hedge funds and other institutional investors have recently modified their holdings of HQY. Fifth Third Wealth Advisors LLC raised its position in HealthEquity by 4.2% during the first quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after buying an additional 116 shares during the period. Truist Financial Corp boosted its position in HealthEquity by 4.9% during the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after acquiring an additional 119 shares during the period. Fiduciary Trust Co boosted its position in HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares during the period. Larson Financial Group LLC grew its stake in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in HealthEquity by 9.5% during the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after acquiring an additional 168 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.